You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Santen

Showing 1 - 25 of 147
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Disease Trial in Jakarta Pusat (Diquafosol sodium 3%, Sodium hyaluronate 0.1%)

Recruiting
  • Dry Eye Disease
  • Diquafosol sodium 3%
  • Sodium hyaluronate 0.1%
  • Jakarta Pusat, Jakarta, Indonesia
    RSUPN Dr. Cipto Mangunkusumo
Nov 24, 2023

Glaucoma Trial in Belgium (AI algorithm for the detection of glaucoma)

Not yet recruiting
  • Glaucoma
  • AI algorithm for the detection of glaucoma
  • Edegem, Antwerpen, Belgium
  • +7 more
Jan 19, 2023

The Proportion of Patients Diagnosed With Dry Eye by Asia Dry

Active, not recruiting
  • Dry Eye Syndromes
  • No intervention
  • Kaohsiung city, Taiwan
  • +2 more
May 25, 2022

Diabetic Eye Problems Trial in Shenyang (3% Diquafosol tetrasodium)

Not yet recruiting
  • Diabetic Eye Problems
  • 3% Diquafosol tetrasodium
  • Shenyang, Liaoning, China
    He Eye Hospital
Feb 14, 2022

3% Diquafosol Before and After Cataract Surgery

Recruiting
  • Dry Eye
  • Ipoh, Perak, Malaysia
    LEC Eye Centre
Jul 6, 2021

Primary Congenital Glaucoma, Developmental Glaucoma Trial (Santen PRESERFLO MicroShunt, Trabeculectomy)

Not yet recruiting
  • Primary Congenital Glaucoma
  • Developmental Glaucoma
  • Santen PRESERFLO MicroShunt
  • Trabeculectomy
  • (no location specified)
Dec 1, 2020

Retinopathy of Prematurity Trial (0.5% cyclopentolate and 2.5% phenylephrine, 0.5% tropicamide + 0.5% phenylephrine, 0.5%

Completed
  • Retinopathy of Prematurity
  • 0.5% cyclopentolate and 2.5% phenylephrine
  • +2 more
  • (no location specified)
Apr 8, 2021

Uveitis, Intermediate Uveitis, Posterior Uveitis Trial in Palo Alto (Intravitreal injection 440mcg, Intravitreal injection of

Recruiting
  • Uveitis
  • +3 more
  • Intravitreal injection 440mcg
  • Intravitreal injection of sirolimus 880mcg
  • Palo Alto, California
    Stanford University
May 5, 2021

Dry Eye, Dry Eye Syndromes, Severe Keratitis Trial in Valladolid (IKERVIS®1mg/mL)

Completed
  • Dry Eye
  • +2 more
  • Valladolid, Spain
    Institute of Applied Ophthalmobiology (IOBA)
Apr 20, 2021

Glaucoma, Open-Angle Trial in Thessaloníki (Tafluprost/timolol fixed combination)

Completed
  • Glaucoma, Open-Angle
  • Tafluprost/timolol fixed combination
  • Thessaloníki, Makedonia, Greece
    1st University Department of Ophthalmology
Dec 16, 2020

Vienna Preserflo Cohort Study

Unknown status
  • Glaucoma
  • +4 more
  • Santen Preserflo Microshunt
  • Vienna, Austria
    Insitute of Ophthalmology and Optometry, Medical University of V
Sep 1, 2020

Endophthalmitis Postoperative Trial in Cheras (Levofloxacin Ophthalmic Product, Moxifloxacin Ophthalmic Solution)

Unknown status
  • Endophthalmitis Postoperative
  • Levofloxacin Ophthalmic Product
  • Moxifloxacin Ophthalmic Solution
  • Cheras, Kuala Lumpur, Malaysia
    UKM Medical Centre
Oct 12, 2020

Endophthalmitis Trial in Cheras, Kuala Lumpur (Levofloxacin Ophthalmic Solution, Moxifloxacin Ophthalmic Solution)

Unknown status
  • Endophthalmitis
  • Levofloxacin Ophthalmic Solution
  • Moxifloxacin Ophthalmic Solution
  • Cheras, Kuala Lumpur, Malaysia
  • +1 more
Oct 12, 2020

Endophthalmitis Postoperative Trial in Kuala Lumpur (Levofloxacin Ophthalmic, Cefuroxime)

Unknown status
  • Endophthalmitis Postoperative
  • Kuala Lumpur, Wilayah Persekutuan, Malaysia
    UKM Medical Centre
Sep 18, 2020

Healthy Adult Males Volunteers Trial in Osaka (STN1012600 ophthalmic solution 0.002%)

Recruiting
  • Healthy Adult Males Volunteers
  • STN1012600 ophthalmic solution 0.002%
  • Osaka, Japan
    Medical Corporation Heishinkai OPHAC Hospital
Jun 6, 2023

Presbyopia Trial in Glendale, Memphis (0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo)

Recruiting
  • Presbyopia
  • 0.1% STN1013600 ophthalmic solution
  • +2 more
  • Glendale, California
  • +1 more
Jan 12, 2023

Fuchs Endothelial Corneal Dystrophy Trial in Indianapolis, Houston (STN1010904 ophthalmic suspension 0.03% BID, STN1010904

Recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • STN1010904 ophthalmic suspension 0.03% BID
  • +2 more
  • Indianapolis, Indiana
  • +7 more
Jan 31, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution

Recruiting
  • Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
  • Aichi, Japan
  • +15 more
Aug 16, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, Latanoprost ophthalmic

Recruiting
  • Primary Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • Latanoprost ophthalmic solution 0.005%
  • Aichi, Japan
  • +42 more
Aug 9, 2022

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /

Completed
  • Ocular Surface Disease
  • Primary Open Angle Glaucoma
  • Tafluprost, timolol maleate
  • Taoyuan city, Taiwan
    Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022

Dry Eye Syndromes Trial in France, Poland, Spain (Cationorm Pro, Vismed)

Recruiting
  • Dry Eye Syndromes
  • Cationorm Pro
  • Vismed
  • La Rochefoucauld, France
  • +9 more
May 16, 2022

Dry Eye Syndromes Trial in France (Alocross 0.2% Unit Dose, Vismed)

Recruiting
  • Dry Eye Syndromes
  • Alocross 0.2% Unit Dose
  • Vismed
  • Bordeaux, France
  • +9 more
May 16, 2022

MGD-Meibomian Gland Dysfunction Trial in Wuhan, Hangzhou (Intense pulsed light, 0.3% hyaluronic acid eye drops)

Completed
  • MGD-Meibomian Gland Dysfunction
  • Intense pulsed light
  • 0.3% hyaluronic acid eye drops
  • Wuhan, Hubei, China
  • +2 more
Sep 11, 2023

NorMIGS - a Study of Micro-invasive Glaucoma Surgery

Recruiting
  • Glaucoma
  • Preserflo microshunt
  • +2 more
  • Oslo, Norway
    Department of Ophthalmology, Oslo University Hospital
Nov 26, 2022

Telehealth and Meal Replacement Pilot Program for Diabetes

Recruiting
  • Diabetes Mellitus, Type 2
  • nutrisystem-D
  • Charlottesville, Virginia
    University of Virginia
May 8, 2021